2,344
Views
33
CrossRef citations to date
0
Altmetric
Research Article

The application of anethole, menthone, and eugenol in transdermal penetration of valsartan: Enhancement and mechanistic investigation

, &
Pages 1042-1051 | Received 30 Mar 2015, Accepted 22 Sep 2015, Published online: 29 Oct 2015

References

  • Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Aqil M, Kohli K. 2013a. Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv. 10:1137–1153.
  • Ahad A, Al-Mohizea AM, Al-Jenoobi FI, Aqil M. 2014a. Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.942444.
  • Ahad A, Al-Saleh AA, Akhtar N, Al-Mohizea AM, Al-Jenoobi FI. 2015. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies. Drug Discov Today. [Epub ahead of print]. doi: 10.1016/j.drudis.2015.06.002.
  • Ahad A, Aqil M, Ali A. 2014b. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole. Int J Biol Macromol. 64:144–149.
  • Ahad A, Aqil M, Kohli K, Chaudhary H, Sultana Y, Mujeeb M, Talegaonkar S. 2009. Chemical penetration enhancers: a patent review. Expert Opin Ther Pat. 19:969–988.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011a. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Deliv. 8:213–224.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011b. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm. 37:583–596.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2012. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine. 8:237–249.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. 2013b. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm. 443:26–38.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. 2014c. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats. Expert Opin Drug Deliv. 11:1149–1162.
  • Akbari J, Saeedi M, Farzin D, Morteza-Semnani K, Esmaili Z. 2015. Transdermal absorption enhancing effect of the essential oil of Rosmarinus officinalis on percutaneous absorption of Na diclofenac from topical gel. Pharm Biol. 53:1442–1447.
  • Amin S, Kohli K, Khar RK, Mir SR, Pillai KK. 2008. Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers. Pharm Dev Technol. 13:533–539.
  • Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T. 2005. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm. 289:167–178.
  • Aqil M, Ahad A, Sultana Y, Ali A. 2007. Status of terpenes as skin penetration enhancers. Drug Discov Today. 12:1061–1067.
  • El-Kattan AF, Asbill CS, Michniak BB. 2000. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm. 198:179–189.
  • Fang C, Liu Y, Ye X, Rong ZX, Feng XM, Jiang CB, Chen HZ. 2008. Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. Eur J Pharm Biopharm. 68:735–740.
  • Geinoz S, Guy RH, Testa B, Carrupt PA. 2004. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm Res. 21:83–92.
  • Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A. 2004. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release. 99:113–125.
  • Gumming KI, Winfield AJ. 1994. In vitro evaluation of a series of sodium carboxylates as dermal penetration enhancers. Int J Pharmaceut. 108:141–148.
  • Hassan N, Ahad A, Ali M, Ali J. 2010. Chemical permeation enhancers for transbuccal drug delivery. Expert Opin Drug Deliv. 7:97–112.
  • Jain AK, Thomas NS, Panchagnula R. 2002. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release. 79:93–101.
  • Kang L, Yap CW, Lim PF, Chen YZ, Ho PC, Chan YW, Wong GP, Chan SY. 2007. Formulation development of transdermal dosage forms: quantitative structure–activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. J Control Release. 120:211–219.
  • Kararli TT, Kirchhoff CF, Penzotti SC. 1995. Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene-like enhancers: in vivo–in vitro correlations. J Control Release. 34:43–51.
  • Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. 2005. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. J Control Release. 106:111–122.
  • Krishnaiah YS, Al-Saidan SM, Jayaram B. 2006. Effect of nerodilol, carvone and anethole on the in vitro transdermal delivery of selegiline hydrochloride. Pharmazie. 61:46–53.
  • Krishnaiah YS, Satyanarayana V, Bhaskar P. 2002a. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int J Pharm. 247:91–102.
  • Krishnaiah YS, Satyanarayana V, Bhaskar P. 2003. Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers. Eur J Pharm Biopharm. 55:329–337.
  • Krishnaiah YS, Satyanarayana V, Karthikeyan RS. 2002b. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J Pharm Pharm Sci. 5:123–130.
  • Kunta JR, Goskonda VR, Brotherton HO, Khan MA, Reddy IK. 1997. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J Pharm Sci. 86:1369–1373.
  • Lee PJ, Langer R, Shastri VP. 2005. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci. 94:912–917.
  • Levison KK, Takayama K, Isowa K, Okabe K, Nagai T. 1994. Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci. 83:1367–1372.
  • Manosroi A, Jantrawut P, Akazawa H, Akihisa T, Manosroi W, Manosroi J. 2011a. Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls. Pharm Biol. 49:553–562.
  • Manosroi A, Jantrawut P, Akihisa T, Manosroi W, Manosroi J. 2011b. In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol. 49:1190–1203.
  • Moghimi HR, Makhmalzadeh BS, Manafi A. 2009. Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar. Burns. 35:1165–1170.
  • Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. 2009. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 380:72–79.
  • Narishetty ST, Panchagnula R. 2004a. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release. 95:367–379.
  • Narishetty ST, Panchagnula R. 2004b. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation. Biopharm Drug Dispos. 25:9–20.
  • Nishida N, Taniyama K, Sawabe T, Manome Y. 2010. Development and evaluation of a monolithic drug-in-adhesive patch for valsartan. Int J Pharm. 402:103–109.
  • Okabe H, Takayama K, Ogura A, Nagai T. 1989. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des Deliv. 4:313–321.
  • Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. 2001. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 219:95–105.
  • Rhee YS, Chang SY, Park CW, Chi SC, Park ES. 2008. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration. Int J Pharm. 364:14–20.
  • Rizwan M, Aqil M, Ahad A, Sultana Y, Ali MM. 2008. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm. 34:618–626.
  • Roberts MS. 1997. Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease. Clin Exp Pharmacol Physiol. 24:874–879.
  • Sapra B, Jain S, Tiwary AK. 2008. Percutaneous permeation enhancement by terpenes: mechanistic view. AAPS J. 10:120–132.
  • Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. 2008. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol. 6:8.
  • Shirakura O, Ohshima A, Tsunemi S, Ishimaru S, Sakaguchi T, Takayama K, Nagai T. 1995. Synergistic effect of d-limonene and ethanol on the transdermal permeation of NB-818. Drug Dev Ind Pharm. 21:411–425.
  • Tatar S, Saglik S. 2002. Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J Pharm Biomed Anal. 30:371–375.
  • Tenjarla SN, Kasina R, Puranajoti P, Omar MS, Harris WT. 1999. Synthesis and evaluation of N-acetylprolinate esters – novel skin penetration enhancers. Int J Pharm. 192:147–158.
  • Thomas NS, Panchagnula R. 2003. Combination strategies to enhance transdermal permeation of zidovudine (AZT). Pharmazie. 58:895–898.
  • Vaddi HK, Ho PC, Chan SY. 2002a. Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci. 91:1639–1651.
  • Vaddi HK, Ho PC, Chan YW, Chan SY. 2002b. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J Control Release. 81:121–133.
  • Vashistha I, Ahad A, Aqil M, Agarwala SP. 2014. Investigating the potential of essential oils as penetration enhancer for transdermal losartan delivery: effectiveness and mechanism of action. Asian J Pharm Sci. 9:260–267.
  • Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv Rev. 56:603–618.
  • Yamane MA, Williams AC, Barry BW. 1995. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol. 47:978–989.
  • Yamashita F, Hashida M. 2003. Mechanistic and empirical modeling of skin permeation of drugs. Adv Drug Deliv Rev. 55:1185–1199.
  • Zhao K, Singh J. 1998. Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, d-limonene and menthone. J Control Release. 55:253–260.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.